Product Information
M2698 is a monoclonal antibody that binds to the epithelial growth factor receptor (EGFR) and inhibits tumor cell growth. M2698 has been shown to inhibit tumor cell proliferation in vitro and in vivo, as well as decrease tumor size in mice. The drug also has therapeutic potential for breast cancer patients who have HER2+ tumors. M2698 is currently undergoing Phase I clinical trials for the treatment of breast cancer with high levels of HER2 protein expression.
Chemical properties
Technical inquiry about: 3D-EFC54595 M2698
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.